Aquaculture vaccines market share has been witnessing increased traction owing to the growing incidence of fish infections among aquaculture species across the world. Fish farming is one of the prominent businesses across the globe, owing to rising fish consumption that is beneficial for health. But as fish are extremely vulnerable to bacterial and viral infections, they are required to be regularly treated with antibiotics or vaccines.

Recent research has found that growing implementation of antibiotics has been leading toward negative effects on fish health, such as deteriorating resistance power and prevalent reoccurrence of the diseases. Whereas, vaccines tend to provide superior protection against bacterial and viral infections without triggering any negative outcomes on fish health, which will be a major factor augmenting aquaculture vaccines market trends.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3323

Growing incidence of bacterial fish diseases is a major challenge that harshly affects the fish production. As per the National Institute of Health (NIH), bacterial diseases account for about 54.9% of the fish farms disease manifestations. Thereby, increasing R&Ds to discover new methods of producing novel vaccines will impel positive business outlook for aquaculture vaccines market.

The UK aquaculture vaccines market held a significant share in 2018 and is projected to accumulate over USD 29.2 million by 2025. The country has been witnessing increasing product consumption promoted by the favorable government initiatives to protect several fish species on verge of extinction. Growing preferences for vaccines over antibiotics will drive UK aquaculture vaccines industry share over 2019-2025.

Providers of various types of aquaculture vaccines are focusing on R&D initiatives to increase their footprint and expand their offerings across the globe. For instance, Merck & Co acquired Antelliq Corporation, an animal health-based digital firm in April 2019 to offer digital solutions towards its animal healthcare.

The ongoing coronavirus pandemic has pushed the need for novel strategic frameworks by these companies to gain a competitive edge over other participants. For instance, Touchlight Genetics, a vaccine manufacturer, partnered with Stonehaven Incubate in September 2020, to launch Touchlight Aquaculture, a joint venture firm that uses advanced technologies from both contributors to develop new vaccines.

Hipra, Zoetis Inc., Tecnovax, Veterquimica S.A., Virbac, and Nisseiken Co. Ltd are some of the other global brands in the business.

Request for customization @ https://www.decresearch.com/roc/3323

Partial Chapter of the Table of Content

Chapter 4.    Aquaculture Vaccines Market, By Type of Vaccines

4.1. Key segment trends

4.2. Inactivated vaccines

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3. Live vaccines

4.3.1. Market size, by region, 2014 – 2025  (USD Million)

4.4. Others

4.4.1. Market size, by region, 2014 – 2025  (USD Million)

Chapter 5.    Aquaculture Vaccines Market, By Route of Administration

5.1. Key segment trends

5.2. Immersion vaccines

5.2.1.  Market size, by region, 2014 – 2025 (USD Million)

5.3. Injection vaccines

5.3.1.  Market size, by region, 2014 – 2025 (USD Million)

5.4. Oral vaccines

5.4.1.  Market size, by region, 2014 – 2025 (USD Million)

Chapter 6.    Aquaculture Vaccines Market, By Application

6.1.  Key segment trends

6.2.  Bacterial infection

6.2.1.    Market size, by region, 2014 – 2025 (USD Million)

6.3.  Viral infection

6.3.1.    Market size, by region, 2014 – 2025 (USD Million)

6.4.  Others

6.4.1.    Market size, by region, 2014 – 2025  (USD Million)

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/aquaculture-vaccines-market